ImmunologybioRxivPreprint
An ex vivo human model for safety assessment of immunotoxicity of engineered nanomaterials
J. Blersch, B. Kurkowsky, A. Meyer-Berhorn…·E. Fava
This paper introduces an ex vivo human model using PBMCs to assess immunotoxicity of engineered nanomaterials through high-throughput, automated assays with dose-response data and multiparametric readouts.
DOI 10.1101/2023.06.29.547008